Munafa Stock Market Course + Intraday & FNO calls 
Biomarin Pharmaceutical (BMRN) Technical (Analysis) Reports Biomarin Pharmaceutical ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Biomarin Pharmaceutical (BMRN)
Technical Analysis Report for NASDAQ stock BMRN Biomarin Pharmaceutical. Dated: 26 Aug 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock BMRN Biomarin Pharmaceutical then click here. or read Experts views on Biomarin Pharmaceutical or Forecast & share price targets of Biomarin Pharmaceutical
Biomarin Pharmaceutical Opened at 65.62 and Closed at: 65.61, which is -0.78% of previous session's close. It moved within a range of 65.33 and 66.53
The session was a Bearish session with an average volume of 1884300, which is 27.91% of previous session's volumes.
- Even though the stock has fallen, but its short term trend is positive and in an uptrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
Support for tomorrow is 64.87 and resistance for tomorrow is 66.07
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 65.12, 64.62 resistance for tomorrow's hourly charts is 66.32, 67.02
10 Day SMA for Biomarin Pharmaceutical (BMRN) is 67.01 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Biomarin Pharmaceutical (BMRN) is 65.26 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Biomarin Pharmaceutical (BMRN) is 61.3 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 57.8 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Biomarin Pharmaceutical is 57.51 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Biomarin Pharmaceutical is at 65.26 and 200 DMA is at 57.51, while 50 DMA and 100 DMA are at 61.3 and 57.8 respectively
Biomarin Pharmaceutical (BMRN) moving average of 20 SMA is at 65.26 and 20 EMA is at 65.26
| Date | Closing Price | 20 SMA | 20 EMA |
| 26 Wed Aug | 65.61 | 65.26 | 65.26 |
| 25 Tue Aug | 66.12 | 65.05 | 65.22 |
| 24 Mon Aug | 65.07 | 64.85 | 65.13 |
| 21 Fri Aug | 66.70 | 64.61 | 65.14 |
| 20 Thu Aug | 67.68 | 64.24 | 64.98 |
| 19 Wed Aug | 69.36 | 63.82 | 64.7 |
Biomarin Pharmaceutical (BMRN) moving average of 50 SMA is at 61.3 and 50 EMA is at 62.17
| Date | Closing Price | 50 SMA | 50 EMA |
| 26 Wed Aug | 65.61 | 61.3 | 62.17 |
| 25 Tue Aug | 66.12 | 61.09 | 62.03 |
| 24 Mon Aug | 65.07 | 60.88 | 61.86 |
| 21 Fri Aug | 66.70 | 60.7 | 61.73 |
| 20 Thu Aug | 67.68 | 60.48 | 61.53 |
| 19 Wed Aug | 69.36 | 60.25 | 61.28 |
Biomarin Pharmaceutical (BMRN) moving average of 100 SMA is at 57.8 and 100 EMA is at 59.82
| Date | Closing Price | 100 SMA | 100 EMA |
| 26 Wed Aug | 65.61 | 57.8 | 59.82 |
| 25 Tue Aug | 66.12 | 57.71 | 59.7 |
| 24 Mon Aug | 65.07 | 57.61 | 59.57 |
| 21 Fri Aug | 66.70 | 57.51 | 59.46 |
| 20 Thu Aug | 67.68 | 57.42 | 59.31 |
| 19 Wed Aug | 69.36 | 57.31 | 59.14 |
Biomarin Pharmaceutical (BMRN) moving average of 200 SMA is at 57.51 and 200 EMA is at 58.72
| Date | Closing Price | 200 SMA | 200 EMA |
| 26 Wed Aug | 65.61 | 57.51 | 58.72 |
| 25 Tue Aug | 66.12 | 57.45 | 58.65 |
| 24 Mon Aug | 65.07 | 57.37 | 58.57 |
| 21 Fri Aug | 66.70 | 57.31 | 58.5 |
| 20 Thu Aug | 67.68 | 57.24 | 58.42 |
| 19 Wed Aug | 69.36 | 57.16 | 58.33 |
Biomarin Pharmaceutical has performed better than Dentsply Sirona in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Meridian Bioscience has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Meridian Bioscience, about 10.63% more returns!
Sarepta Therapeutics has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Sarepta Therapeutics, about 16.76% more returns!
Sellas Life has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Sellas Life, about 25.13% more returns!
Biomarin Pharmaceutical has performed better than Sol Gel in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Radnet Inc has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Radnet Inc, about 13.68% more returns!
Opko Health has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Opko Health, about 4.39% more returns!
Biomarin Pharmaceutical has performed better than Nektar Therapeutics in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Meiragtx Holdings has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Meiragtx Holdings, about 13.24% more returns!
Kura Oncology has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Kura Oncology, about 31.98% more returns!
Biomarin Pharmaceutical has performed better than Icu Medical in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Biomarin Pharmaceutical has performed better than Heron Therapeutics in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Biomarin Pharmaceutical has performed better than Chemocentryx Inc in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Amgen Inc has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Amgen Inc, about 5.3% more returns!
Alnylam Pharmaceuticals has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Alnylam Pharmaceuticals, about 8.01% more returns!
Akari Therapeutics has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Akari Therapeutics, about 5.45% more returns!
Biomarin Pharmaceutical Technical analysis of indicators
Price action analysis of Biomarin Pharmaceutical (BMRN) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Biomarin Pharmaceutical in short term but the sell signal is initial and weak.
Biomarin Pharmaceutical Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Biomarin Pharmaceutical in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Biomarin Pharmaceutical is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 66.88 and Biomarin Pharmaceutical BMRN stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Biomarin Pharmaceutical BMRN stock. Volume based technical analysis of Biomarin Pharmaceutical BMRN stock is negative.
Biomarin Pharmaceutical Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock BMRN Biomarin Pharmaceutical These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And BMRN Experts View which covers a lot of information including buying and selling signals
BMRN future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Biomarin Pharmaceutical or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Biomarin Pharmaceutical (BMRN) Technical (Analysis) Reports Biomarin Pharmaceutical ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
